Introduction
============

Surgical site infections (SSIs) are the most common type of health care-associated infections (HAIs) in patients undergoing surgery and remain a major source of postoperative morbidity. Among surgical patients, SSIs account for 38% of HAIs.[@b1-idr-11-1373] Among patients undergoing gastrointestinal (GI) surgeries, 12.2% develop SSIs,[@b2-idr-11-1373] which result in prolonged hospitalization, increased morbidity and mortality, and increased surgery-related costs. Therefore, to reduce SSI, it is important to investigate risk factors, and these have been well studied in various types of GI surgeries, particularly colorectal surgery.[@b1-idr-11-1373] Epidemiological studies have identified risk factors as well as protective factors for SSIs including, but not limited to, demographic factors, preoperative preparation, and laparoscopic procedures.[@b2-idr-11-1373]

Surveillance of SSIs should be a priority for infection-control programs, and SSI surveillance has been implemented in Kuwait as part of the Kuwait National Healthcare-associated Infections Surveillance System (KNHSS) which adopted the guidelines issued by the National Health Safety Network (NHSN) that are updated regularly. The SSI surveillance system specifies operative procedures for each governmental hospital, including the GI procedures -- namely, colon (COLO), gastric (GAST), and small bowel (SB) surgeries. This study aimed to measure SSI rates among the selected GI surgeries and to identify the associated potential risk factors.

Patients and methods
====================

Setting and design
------------------

A descriptive, retrospective, multicenter study of the collected GI-SSI surveillance from all governmental hospitals in all health regions in Kuwait was conducted. The bed capacity of participating hospitals ranged from 400 to 900 beds. All adult patients who underwent the selected GI surgeries from January to December 2016 in all Kuwait governmental hospitals were evaluated in this study.

Data collection
---------------

The Kuwait Infection Control Directorate had assigned select GI surgeries -- COLO, GAST, and SB -- for inclusion under the KNHSS. These assignments were based on previously analyzed SSI rates at each hospital. Data for the current study were retrieved from the SSI forms (denominator, nominator, and post-discharge forms) for the selected GI procedures. During the surveillance period, all operated patients were prospectively and actively monitored for signs of SSI for 1 month through the KNHSS. The surgical denominator form was filled for each procedure in all governmental hospitals by trained infection-control staff. This denominator form included: patient name, gender, nationality, hospital file number, procedure name, code, date and duration, wound class, American Society for Anesthesiologists (ASA) score, scope use, emergency or non-emergency, and the SSI Risk Index category. SSI was diagnosed during the primary patient hospitalization, after discharge, or re-hospitalization by using the following methods.

### Ante-discharge surveillance method

This method was used for the diagnosis of postoperative SSI during the primary patient hospitalization. For patients who developed SSIs, a numerator form was filled that included: patient name, gender, nationality, hospital file number, procedure name, code, date of procedure and infection event, SSI category, SSI signs, symptoms, laboratory diagnosis, physician diagnosis, pathogen identified, pathogen susceptibility, occurrence of secondary bloodstream infection, and patient outcome (death or discharge).

### Post-discharge surveillance method

The post-discharge surveillance method was used for the diagnosis of SSIs after patient discharge or at readmission. The post-discharge surveillance form was filled for patients who presented with SSI to outpatient clinics in primary health care or any governmental hospital. This post-discharge surveillance form included the name of the hospital where the operation was done and the reporting facility in addition to patients' demographic data. For those diagnosed after discharge or readmission, the previously described nominator form was additionally filled.

The state of Kuwait is divided into six health regions and according to the residential address of people seeking medical care in each health region. Self-treatment is very difficult; all patients visit the primary health care or health regions hospitals to receive antibiotics (if needed) as there are no over-the-counter medications. Postoperatively and before the patients' discharge, the staff nurses do the following: educate patients about signs and symptoms of wound infection, schedule each patient for regular wound dressing (follow-up visits), and instruct patients to visit the hospital, even outside of consultation hours, if any signs or symptoms of SSI develop. During the follow-up visits, each patient was examined for signs of SSI and wound dressing done in primary health care or regional hospitals clinics based on the previous written follow-up visits, depending upon appointment and residential address. Infection-control staff actively and periodically follow-up these patients under the post-discharge surveillance method in primary health care and hospitals. Any case that was diagnosed in Kuwait governmental health care facilities after patient discharge was reported, and the complete data were collected (numerator forms were filled).

All the previously described tools (forms) were distributed to all primary health care centers and governmental hospitals. All infection-control and nursing staff in these locations were trained on the use of these previously described methods. All filled forms were collected regularly from all governmental sectors.

Definitions
-----------

The criteria used to define SSIs and a patient's risk index categories were established according to the US Centers for Disease Control and Prevention (CDC) guidelines. SSIs were classified into three groups: superficial, involving skin and subcutaneous tissue; deep, involving muscle and fascia; and organ space.[@b3-idr-11-1373] According to the NHSN that was adapted from the American College of Surgeons classification, wounds were classified into four classes: clean, clean-contaminated, contaminated, or dirty-infected.[@b4-idr-11-1373] The NHSN cutoff point (75th percentile) for the duration of the operative procedures was specified in minutes: 187 for COLO, 160 for GAST, and 192 for SB surgeries.[@b5-idr-11-1373] The ASA score was based on an assessment by the anesthesiologist of the patient's preoperative physical condition using the ASA classification. The NHSN surgical risk index category was calculated for all operated patients. The NHSN SSI Risk Index ranges from 0 (lowest risk) to 3 (greatest risk),[@b6-idr-11-1373] and is the sum of a number of risk factors: 1) a patient with an ASA score of 3, 4, or 5; 2) an operative wound classified as contaminated or dirty/infected; and 3) an operation lasting longer than the duration cutoff point. Each risk factor listed was considered as one risk according to the NHSN risk index.[@b6-idr-11-1373] Patients with SSIs were defined as patients who underwent the selected surgeries during the study period at any of Kuwait's governmental hospitals and acquired an SSI according to the CDC criteria.

Exclusion criteria
------------------

Operated patients for the selected procedures who had undergone nonprimary closure of the wound and developed an infection would not be considered to have an SSI and were excluded from this study according to the KNHSS.[@b4-idr-11-1373]

Ethical considerations
----------------------

The study protocol was reviewed and approved by the Kuwait Ministry of Health Standing Committee for the Coordination of Health and Medical Research, and patient confidentiality was protected; all data were entered and analyzed anonymously.

Statistical analysis
--------------------

Data were coded, entered anonymously, and analyzed using SPSS version 19. Qualitative variables were presented as frequency (%); quantitative variables were presented as the median and interquartile range. Chi-squared or Fisher's exact test were used to compare qualitative variables values, whereas the Mann--Whitney *U* test was used to compare quantitative variables. SSI rates per 100 operative procedures were calculated for each selected procedure according to the CDC/NHSN, SSI protocol 2013. Binary logistic multivariate regression analysis was conducted for the statistically significant variables identified by the univariate analysis to determine independent predictive factors for the development of SSI. A *P*-value of \<0.05 was considered statistically significant.

Results
=======

Patient characteristics and potential risk factors
--------------------------------------------------

A total of 2,099 patients met the eligibility criteria for GI surgeries: 1,722 GAST, 192 COLO, and 185 SB included in this study. The characteristics and potential risk factors of the study participants are summarized in [Tables 1](#t1-idr-11-1373){ref-type="table"}[](#t2-idr-11-1373){ref-type="table"}--[3](#t3-idr-11-1373){ref-type="table"}.

### GAST surgery

Univariate analysis of risk factors showed that the median duration of surgery in the SSI group was longer than in the non-SSI group (122.5 vs 90 minutes, respectively, *P*=0.02). Moreover, it showed that, in the SSI group, there was a trend toward statistical significance for emergency surgery as well as higher wound class, scope use, and risk index (*P*\<0.001; [Table 1](#t1-idr-11-1373){ref-type="table"}). Bariatric surgeries represented 96%, and the scope was used in 96% of these surgeries. Scope use had a protective effect (*P*≤0.05; results not shown).

### COLO surgery

The SSI group had a statistically significant longer median duration of operative time compared to the non-SSI group -- 195 vs 150 minutes, respectively (*P*\<0.001; [Table 2](#t2-idr-11-1373){ref-type="table"}).

### SB surgery

Half of the subjects in the SSI group were emergency cases, with a statistically significant difference between the SSI and non-SSI groups (*P*=0.02; [Table 3](#t3-idr-11-1373){ref-type="table"}).

Characteristics of SSIs
-----------------------

SSIs were noted in 71 patients out of 2,099: 13 patients following GAST surgery (incidence rate 0.8%), 38 patients following COLO surgery (incidence rate 19.8%), and 20 patients following SB surgery (incidence rate 10.8%). The superficial SSI rate vs deep/organ space SSI rate was, respectively, 13.5% and 6.3% in COLO, 0.2% and 0.5% in GAST, and 4.8% and 7.3% in SB surgeries. With regard to the time of diagnosis, the vast majority of patients with SSIs following COLO surgery (94.7%), all SSIs after SB surgery, and 61.5% following GAST surgery were diagnosed during the primary hospital admission. Besides this, the SSI diagnosis was established after hospital discharge consecutively in 38.5% and 5.2% of patients following GAST and COLO surgeries ([Table 4](#t4-idr-11-1373){ref-type="table"}). A high percentage of infected wounds following SB and COLO surgeries had multiple microbial infections -- 63.2% and 41.2%, respectively -- whereas in 75% of infected wounds following GAST surgery a single pathogen was isolated as shown in [Table 4](#t4-idr-11-1373){ref-type="table"}. The SSI rate following bariatric surgeries was 0.4% compared with 9.4% among non-bariatrics and 14.3% among cancer stomach surgeries, and the difference between the groups was statistically significant (*P*\<0.001; data not shown).

Logistic regression analysis
----------------------------

Binary logistic multivariate analysis was done using all the significant variables for the SSI group identified in the univariate analysis for GAST surgery. Age at surgery, operative duration, wound class, emergency SSI Risk Index, and laparoscopic approach were dependent factors affecting occurrence of SSI. However, the laparoscopic approach was the only significant predictor with a protective effect against developing SSIs as compared to open GAST surgery (*P*≤0.05). The overall prediction of the regression model was 26.4% (*P*\<0.001; [Table 5](#t5-idr-11-1373){ref-type="table"}).

Causative pathogens
-------------------

Pathogens associated with SSI were isolated from 91.5% of patient wounds of the studied surgical categories. Among COLO, GAST, and SB SSIs, 41.2%, 25.0%, and 63.2%, respectively, were caused by multiple microbes. Among the pathogens isolated from COLO SSIs, Gram-negative bacilli (GNB) were the main causative pathogen (representing 70% of SSIs), and more than half of these GNB (60.0%) were multidrug-resistant organisms (MDROs) -- most (81.1%) being an extended-spectrum β-lactam producer (ESBL). *Escherichia coli* (46%) and *Enterococcus* spp. (24%) were the most common isolated pathogen. In GAST-SSI, GNB were the commonest pathogens 43.8%, of which 42.9% were *Pseudomonas aeruginosa* MDRO. The *Candida* spp. represented 37.5% of the isolated pathogens. Among the pathogens isolated from SB-SSIs, 64.1% were GNB and 27.7% were Gram-positive cocci and candida. MDROs represented 59.1% of the GNB; of these, 61.5% were ESBL, and *E. coli* was the most commonly isolated pathogen (25%; [Table 6](#t6-idr-11-1373){ref-type="table"}).

Discussion
==========

SSI rates are an indicator of health care quality.[@b7-idr-11-1373] To our knowledge, this study represents the first attempt in the state of Kuwait to measure SSI rates following COLO, GAST, and SB surgeries and to explore its related risk factors. The potential risk factors for SSI in our patients were assessed. The CDC guidelines specify identification of risk factors for SSIs before operations permits directed preventive strategy.[@b8-idr-11-1373] Therefore, we believe that investigating the risk factors for GI-SSI could suggest targeted preventive interventions.

SSIs were noted in 71 of 2,099 patients: 38 patients following COLO surgery (incidence rate 19.8%), 13 patients following GAST surgery (incidence rate 0.8%), and 20 patients following SB surgery (incidence rate 10.8%). Among colon surgeries, we identified rates of 13.5% superficial and 6.3% deep/organ space SSIs, which are higher than that the SSI rates reported by Lawson et al (6.2% for superficial and 4.7% for deep/organ space infection).[@b9-idr-11-1373] However, in another study, the organ space SSI rate was 7.9%, which is higher than the SSI rate in the present study.[@b10-idr-11-1373] We found that superficial and deep/organ space SSI rates postgastric surgeries were 0.2% and 0.5%, respectively, which were lower than what was reported by other study, with superficial SSI and organ/space SSI rates of 3% and 2%, respectively.[@b11-idr-11-1373] Another study revealed a rate of 6.1% for superficial SSIs.[@b12-idr-11-1373] These variances may be attributed to different patient populations with different risk factors in addition to the different risk factors for superficial and deep/organ-space SSIs.[@b9-idr-11-1373],[@b13-idr-11-1373]

The diagnosis rate of SSI on admission was 100% after SB surgeries and 94.0% following COLO. With the application of post-discharge surveillance, 38% GAST-SSIs and 6% COLO-SSIs were detected during the 30-day follow-up. Different studies have shown that 12%--84% of SSIs are diagnosed after hospital discharge, thereby confirming the importance of post-discharge surveillance in the detection and reporting of SSI rates.[@b14-idr-11-1373]

The observed SSI rate following GAST surgery was 0.8%. This result was lower than those in reports from other studies following GAST surgery, where SSI rates ranged between 1.7% and 4.23%.[@b1-idr-11-1373],[@b15-idr-11-1373] We noticed that bariatric surgeries accounted for the majority of GAST surgeries (96%), with an SSI rate of 0.4%. This rate was lower than that reported in other research works; large series of bariatric surgeries have described SSI rates of between 5.8% and 20%.[@b7-idr-11-1373],[@b16-idr-11-1373] Furthermore, we recognized that the scope was used in 96% of bariatric surgeries and exhibited a protective effect against the development of SSIs among bariatric surgery patients (*P*\<0.001 results not shown), and this might explain our low rate of SSI.

In the present study, univariate analyses of SSI following GAST surgeries revealed a significant relationship between increased age, longer operative duration, and contaminated or dirty wound class in patients with SSI vs those without SSI; regardless of the differences in methodology and study designs, previous investigators have reported similar associations.[@b1-idr-11-1373],[@b17-idr-11-1373] The association between increased age and occurrence of SSIs may be attributed to a decrease in physiological defense mechanisms and immune function.[@b18-idr-11-1373],[@b19-idr-11-1373] Surgical wound classification has been recognized as a predictive factor in developing SSIs after surgery, and the incidence of SSI can be expected in patients with a higher surgical wound class.[@b19-idr-11-1373]

The SSI rate in COLO surgeries was the highest among the studied GI surgeries, with an incidence rate of 19.8%. Colorectal surgeries have been associated with the highest risk of SSIs, predominately because of the heavy bacterial load of the colon and rectum.[@b20-idr-11-1373],[@b21-idr-11-1373] This finding was in concordance with previous studies in different countries, with SSI rates ranging from 14% to 25%.[@b13-idr-11-1373],[@b21-idr-11-1373] On the other hand, the NHSN report displayed lower SSI rates in COLO surgery -- between 4% and 9.5%.[@b15-idr-11-1373]

The current study demonstrated that prolonged operation duration, beyond the cutoff point (\>median), was a significant predictor for the development of SSIs in COLO surgery, and this association had often been described by other researchers.[@b22-idr-11-1373]--[@b24-idr-11-1373] The observed association between longer operative duration and development of SSIs among the studied COLO and GAST surgery patients might be attributable to the increased duration of exposure to microorganisms in the operating theater.[@b25-idr-11-1373],[@b26-idr-11-1373] Therefore, SSI prevention strategies focusing on longer surgical duration are needed to improve patient outcomes.[@b19-idr-11-1373] By applying both univariate and multivariate regression analyses, we found that the laparoscopic approach served as an independent protective factor against the development of SSIs in GAST surgery (*P*=0.001). This finding was described in previous research work where scope use significantly reduced SSI rates.[@b7-idr-11-1373],[@b27-idr-11-1373],[@b28-idr-11-1373] A review of the literature showed scarce research evidence on SSIs following SB surgeries; most researchers had studied SSIs of either the large bowel alone or in combination with SB surgeries.[@b10-idr-11-1373],[@b29-idr-11-1373],[@b30-idr-11-1373] The present study showed that the incidence of SSIs following SB surgery was 10.8%. This rate was higher than the rate in other reports; the NHSN reports SSI rates between 3.5% and 7%.[@b15-idr-11-1373] A retrospective study identified an SSI rate of 8.7% following SB and large bowel surgeries.[@b31-idr-11-1373] Conversely, in a meta-analysis, Fiorio et al demonstrated a higher rate of SSIs following SB surgeries (16.3%).[@b32-idr-11-1373]

Our analysis revealed that the incidence of SSIs among emergency SB surgery was higher than in elective surgery (50% vs 25.5%, *P*=0.021). This finding was concordant with results from other research.[@b28-idr-11-1373] A possible explanation for the higher incidence of SSIs in emergency surgeries could be attributed to inadequate preoperative preparation, as these surgeries usually take place beyond normal clinical working hours. Therefore, it is of high importance to emphasize the management of emergency surgeries.[@b19-idr-11-1373]

Following COLO, GAST, and SB surgeries, a considerable percentage of poly-microbes were isolated. GNB were the most common isolated pathogens, and this finding was comparable with other researches.[@b33-idr-11-1373],[@b34-idr-11-1373] However, other previous studies showed a higher proportion of Gram-positive organisms, which are associated with SSIs in different countries.[@b35-idr-11-1373],[@b36-idr-11-1373] *Staphylococcus aureus*, coagulase-negative *Staphylococcus*, and *E. coli* were the most common organisms associated with SSI according to a recent report by the NHSN.[@b37-idr-11-1373] Moreover, MDROs accounted for a high proportion of the isolated GNB, especially ESBL-producing organisms, following COLO and SB surgeries among our patients. A high proportion of methicillin-resistant *S. aureus* and carbapenem-resistant *Acinetobacter baumannii* isolates were identified in a study of SSIs in large teaching hospital in Southern Italy.[@b38-idr-11-1373] The diversity of the study population and the different antimicrobial use could be the reason for identifying a different pattern of bacterial isolates in different study settings. The majority of GNB identified in our SSI patients were possibly due to the predominance of Gram-negative isolates from SSIs following intra-abdominal procedures.[@b39-idr-11-1373] Our findings highlight the importance of knowing the local epidemiology of antibiotic resistance to facilitate proper selection of prophylactic and therapeutic antibiotics, with subsequent optimization of the outcomes and reduction of the length of hospital stay.[@b40-idr-11-1373]

Strengths and limitations
=========================

Among the strengths of the study are its multi-centric design and the fact that all data were collected by trained infection-control staff. However, the study has limitations that should be admitted. There are certain risk factors that have been linked to SSIs that are not limited to perioperative hyperglycemia, hypothermia, and comorbidities were not recorded in this study. Due to the small number of SB and COLO surgeries, their SSI rates cannot be generalized and further studies are needed.

Conclusion
==========

Variances in SSI rates and risk factors among gastric, colon, and SB surgeries were detected. The use of an endoscope in gastric surgeries exhibited a protective effect against the development of SSIs. The reduction of the SSI rate can be achieved by targeted preventive interventions for the identified risk factors.
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###### 

Patients characteristics and potential risk factors of GAST surgery

  Characteristics                          Total (N=1,722)   With SSI (N=13)   Without SSI (N=1,709)   *P*-value[\*](#tfn1-idr-11-1373){ref-type="table-fn"}
  ---------------------------------------- ----------------- ----------------- ----------------------- -------------------------------------------------------
  Age at surgery, in years, median (IQR)   33 (25--42)       43 (28--57)       33 (25--42)             0.023
  Gender %                                 Male 27.6         Male 30.8         Male 27.6               0.800
                                           Female 72.4       Female 69.2       Female 72.4             
  Duration of surgery in minutes, median   90                122.5             90                      0.020
  ASA score, n (%)                                                                                     
  1+2                                      1,223 (84.1)      9 (75)            1,214 (84.1)            0.390
  3+4                                      232 (15.9)        3 (25)            229 (15.9)              
  ASA unknown                              267               1                 266                     
  Wound class, n (%)                                                                                   
  CC                                       1,664 (96.7)      8 (66.6)          1,656 (97.0)            0.000
  Co + D                                   56 (3.3)          4 (33.3)          52 (3.0)                
  Unknown                                  2                 1                 1                       
  Scope use                                1,644 (95.5)      6 (46.2)          1,638 (95.6)            0.000
  Emergency %                              42 (2.4)          3 (25.0)          39 (2.3)                0.000
  SSI by SSI Risk Index category, n (%)                                                                
  0+1                                      1,406 (96.6)      8 (66.7)          1,398 (96.9)            0.000
  2+3                                      49 (3.4)          4 (33.3)          45 (3.1)                
  Unknown                                  267               1                 266                     

**Notes:**

Chi-squared or Fisher's exact test, the *P*-value used was for categorical variables and in the Mann--Whitney *U* test, the *P*-value used was for continuous variables.

**Abbreviations:** ASA, American Society for Anesthesiologists; CC, clean-contaminated wound; CO, contaminated wound; D, dirty wound; GAST, gastric; IQR, interquartile range; SSI, surgical site infection.

###### 

Patients characteristics and potential risk factors of COLO surgery

  Characteristics[\*](#tfn3-idr-11-1373){ref-type="table-fn"}   Total (N=192)   With SSI (N=38)   Without SSI (N=154)   *P*-value[\*](#tfn3-idr-11-1373){ref-type="table-fn"}
  ------------------------------------------------------------- --------------- ----------------- --------------------- -------------------------------------------------------
  Age at surgery, in years, median (IQR)                        59 (46--70)     54.5 (47--63)     59 (47--70)           0.060
  Gender %                                                      Male 51.9       Male 55.3         Male 51.0             0.638
                                                                Female 48.1     Female 44.7       Female 49.0           
  Duration of surgery in minutes, median                        160             195               150                   0.004
  ASA score, n (%)                                                                                                      
  1+2                                                           104 (64.2)      22 (73.3)         82 (62.0)             0.267
  3+4                                                           57 (35.8)       8 (26.7)          49 (38.0)             
  ASA unknown                                                   31              8                 23                    
  Wound class, n (%)                                                                                                    
  CC                                                            145 (76.3)      30 (78.9)         115 (75.7)            0.670
  Co + D                                                        45 (23.7)       8 (21.1)          37 (24.3)             
  Unknown                                                       2               0                 2                     
  Scope use                                                     39 (20.5)       5 (13.2)          34 (22.4)             0.209
  SSI by SSI Risk Index category, n (%)                                                                                 0.411
  0+1                                                           125 (78.1)      21 (72.4)         104 (83.2)            
  2+3                                                           35 (21.9)       8 (27.6)          27 (20.6)             
  Unknown                                                       32              9                 23                    

**Notes:**

Chi-squared or Fisher's exact test, the *P*-value used was for categorical variables and in the Mann--Whitney *U* test, the *P*-value used was for continuous variables.

**Abbreviations:** ASA, American Society for Anesthesiologists; CC, clean-contaminated wound; CO, contaminated wound; COLO, colon; D, dirty wound; IQR, interquartile range; SSI, surgical site infection.

###### 

Patients characteristics and potential risk factors of SB surgery

  Characteristics                          Total (N=185)   With SSI (N=20)   Without SSI (N=165)   *P*-value[\*](#tfn5-idr-11-1373){ref-type="table-fn"}
  ---------------------------------------- --------------- ----------------- --------------------- -------------------------------------------------------
  Age at surgery, in years, median (IQR)   52 (37--66)     53 (38--67)       51 (36--66)           0.963
  Gender %                                 Male 55.4       Male 70.0         Male 53.7             0.165
                                           Female 44.6     Female 30.0       Female 46.3           
  Duration of surgery in minutes, median   150             150               145                   0.424
  ASA score, n (%)                                                                                 
  1+2                                      104 (63.4)      7 (50)            97 (64.7)             0.276
  3+4                                      60 (36.6)       7 (50)            53 (35.3)             
  ASA unknown                              21              6                 15                    
  Wound class, n (%)                                                                               
  CC                                       106 (57.3)      15 (75)           91 (55.2)             0.090
  Co + D                                   79 (42.7)       5 (25)            74 (44.8)             
  Scope use                                24 (13.0)       2 (10.0)          22 (13.3)             0.675
  Emergency %                              52 (28.1)       10 (50.0)         42 (25.5)             0.021
  SSI by SSI Risk Index category, n (%)                                                            
  0+1                                      118 (72)        10 (71.4)         108 (72)              0.964
  2+3                                      46 (28)         4 (28.6)          42 (28)               
  Unknown                                  21              6                 15                    

**Notes:**

Chi-squared or Fisher's exact test, the *P*-value used was for categorical variables and in the Mann--Whitney *U* test, the *P*-value used was for continuous variables.

**Abbreviations:** ASA, American Society for Anesthesiologists; CC, clean-contaminated wound; CO, contaminated wound; D, dirty wound; IQR, interquartile range; SB, small bowel; SSI, surgical site infection.

###### 

Characteristics of surgical site infections of the studied gastrointestinal surgical categories

  Variables                               COLO SSI/total (38/192)   GAST SSI/total (13/1,722)   SB SSI/total (20/185)
  --------------------------------------- ------------------------- --------------------------- -----------------------
  SSI overall rate, %                     19.8                      0.8                         10.8
  Superficial SSI number (rate %)         26 (13.5)                 4 (0.23)                    8 (4.8)
  Deep + organ space SSI number (%)       5+7 (6.25)                2+7 (0.52)                  4+8 (7.3)
  Time of SSI detection, n (%):                                                                 
  During admission                        36 (94.7)                 8 (61.5)                    20 (100.0)
  Post-discharge surveillance             1 (2.6)                   5 (38.5)                    0 (0.0)
  Readmission to hospital                 1 (2.6)                   0 (0.0)                     0 (0.0)
  SSI with isolated microorganisms (%):   34 (89.5)                 12 (92.3)                   19 (95.0)
  Single (%)                              20 (58.2)                 9 (75.0)                    7 (36.8)
  Multiple (%)                            14 (41.2)                 3 (25.0)                    12 (63.2)

**Abbreviations:** COLO, colon; GAST, gastric; SB, small bowel; SSI, surgical site infection.

###### 

Logistic regression analysis of independent risk factors for surgical site infection following gastric surgery

  Gastric surgery risk factors   B        SE      Wald     95% CI          OR      Sig
  ------------------------------ -------- ------- -------- --------------- ------- -------
  Age                            −0.005   0.009   0.238    0.977--1.014    0.995   0.783
  Wound class                    0.729    0.445   2.686    0.867--4.960    2.074   0.101
  Duration of surgery            −0.003   0.001   3.297    0.994--1.000    0.997   0.522
  SSI Risk Index                 −0.685   0.532   1.654    0.178--1.432    0.504   0.999
  Scope use                      2.765    0.430   41.273   6.831--36.913   15.87   0.000
  Emergency                      −0.623   0.376   2.747    0.257--1.120    0.536   0.536
  Constant                       2.931    0.918   10.192                   18.74   0.001
  Overall percentage                              96.9                             
  Nagelkerke R square                             0.264                            
  Significance of the model                       0.000                            

###### 

Distribution of pathogens identified in surgical site infections of the studied gastrointestinal surgical categories

  Pathogens isolated from SSI           COLO surgery                                            GAST surgery   SB surgery                                                                                                                                                          
  ------------------------------------- ------------------------------------------------------- -------------- ----------------------------------------------- ---------- -------------------------------------------------------------------------------------------------------- ----------
  *Acinetobacter baumannii*             2[\*](#tfn8-idr-11-1373){ref-type="table-fn"}           4                                                                         2[\*](#tfn8-idr-11-1373){ref-type="table-fn"}                                                            5.6
  *Aeromonas hydrophila*                                                                                                                                                  1                                                                                                        2.8
  *Enterobacter cloacae*                                                                                                                                                  2 (1[\*\*\*](#tfn10-idr-11-1373){ref-type="table-fn"})                                                   5.6
  *Enterococcus* spp.                   12                                                      24             1                                               6.25       7                                                                                                        19.4
  *Escherichia coli*                    23 (17[\*\*](#tfn9-idr-11-1373){ref-type="table-fn"})   46             2                                               12.5       9 (6[\*\*](#tfn9-idr-11-1373){ref-type="table-fn"}+2[\*\*\*](#tfn10-idr-11-1373){ref-type="table-fn"})   25
  *Klebsiella* spp.                     2                                                       4              1                                               6.25       2[\*\*](#tfn9-idr-11-1373){ref-type="table-fn"}                                                          5.6
  *Proteus mirabilis*                   1                                                       2              1                                               6.25       1                                                                                                        2.8
  *Pseudomonas aeruginosa*              3                                                       6              3[\*](#tfn8-idr-11-1373){ref-type="table-fn"}   18.75      4                                                                                                        11.1
  *Serratia marcescens*                                                                                                                                                   1                                                                                                        2.8
  *Staphylococcus aureus*               1                                                       2              1                                               6.25                                                                                                                
  Coagulase-negative *staphylococcus*                                                                          1                                               6.25       3                                                                                                        8.3
  Stenotrophomonus malt                 2                                                       4                                                                                                                                                                                  
  *Candida* spp.                        1                                                       2              6                                               37.5       3                                                                                                        8.3
  *Streptococcus* spp.                  1                                                       2                                                                                                                                                                                  
  Gram-negative bacilli                 2[\*](#tfn8-idr-11-1373){ref-type="table-fn"}           4                                                                         1                                                                                                        2.8
  **Total**                             **50**                                                  **100%**       **16**                                          **100%**   **36**                                                                                                   **100%**

**Notes:**

MDRO,

ESBL, and

CRE.

Abbreviations: COLO, colon; GAST, gastric; SB, small bowel; SSI, surgical site infection.
